We are live on ! Find out more
HCM

Hillman Capital Management Portfolio holdings

AUM $138M
1-Year Est. Return 8.57%
This Fund
S&P 500
This Quarter Est. Return
-4.87%
1 Year Est. Return
+8.57%
3 Year Est. Return
+20.19%
5 Year Est. Return
+18.79%
10 Year Est. Return
–
AUM
$270M
AUM Growth
-$22M
Cap. Flow
-$5.75M
Cap. Flow %
-2.13%
Top 10 Hldgs %
34.71%
Holding
60
New
8
Increased
15
Reduced
30
Closed
6
Avg Time Held
12 quarters
Top 10 Avg Time Held
2.7 quarters
Top 20 Avg Time Held
5.9 quarters

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$9.13M
2
DEO icon
Diageo
DEO
+$6.54M
3
BF.B icon
Brown-Forman Class B
BF.B
+$6.43M
4
NKE icon
Nike
NKE
+$2.66M
5
PFE icon
Pfizer
PFE
+$2.41M

Sector Composition

Rank Sector Weight
1 Healthcare 20.37%
2 Communication Services 17.05%
3 Consumer Staples 16.72%
4 Technology 12.53%
5 Consumer Discretionary 10.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AMZN icon
1
Amazon
AMZN
$2.71T
$10.7M 3.96%
48,661
-1,109
-2% -$227K
2021 Q1
15 quarters
T icon
2
AT&T
T
$166B
$10.3M 3.8%
450,176
-10,537
-2% -$237K
2013 Q3
45 quarters
BA icon
3
Boeing
BA
$152B
$10.1M 3.75%
57,098
+9,565
+20% +$1.5M
2020 Q2
18 quarters
WBD icon
4
Warner Bros
WBD
$77.6B
$9.75M 3.62%
922,574
-211,198
-19% -$1.96M
2021 Q2
14 quarters
KMX icon
5
CarMax
KMX
$7.79B
$9.31M 3.45%
113,869
-1,350
-1% -$106K
2022 Q2
10 quarters
MSFT icon
6
Microsoft
MSFT
$3.9T
$9.06M 3.36%
21,487
-2,181
-9% -$929K
2013 Q2
46 quarters
ASML icon
7
ASML
ASML
$714B
$8.81M 3.27%
+12,718
New +$9.13M
2024 Q4
0 quarters
NKE icon
8
Nike
NKE
$50.4B
$8.57M 3.18%
113,255
+33,847
+43% +$2.66M
2024 Q1
3 quarters
DD icon
9
DuPont de Nemours
DD
$17.6B
$8.53M 3.17%
89,147
-1,071
-1% -$111K
2019 Q4
20 quarters
PFE icon
10
Pfizer
PFE
$156B
$8.49M 3.15%
319,969
+88,910
+38% +$2.41M
2023 Q4
4 quarters
ZBH icon
11
Zimmer Biomet
ZBH
$17.5B
$8.34M 3.09%
78,939
-1,748
-2% -$188K
2021 Q3
13 quarters
IFF icon
12
International Flavors & Fragrances
IFF
$21.2B
$8.33M 3.09%
98,540
-1,786
-2% -$168K
2023 Q2
6 quarters
EL icon
13
Estee Lauder
EL
$33.8B
$7.85M 2.91%
104,638
+22,843
+28% +$1.8M
2023 Q4
4 quarters
GSK icon
14
GSK
GSK
$93.3B
$7.82M 2.9%
231,151
+34,255
+17% +$1.23M
2020 Q4
16 quarters
KHC icon
15
The Kraft Heinz Company
KHC
$25.9B
$7.6M 2.82%
247,316
+7,597
+3% +$249K
2019 Q4
20 quarters
DIS icon
16
Walt Disney
DIS
$179B
$7.58M 2.81%
68,065
+85
+0.1% +$8.93K
2022 Q4
8 quarters
CRM icon
17
Salesforce
CRM
$189B
$7.07M 2.62%
21,157
-48
-0.2% -$15.3K
2021 Q2
14 quarters
GOOGL icon
18
Alphabet (Google) Class A
GOOGL
$4.24T
$6.83M 2.54%
36,104
+404
+1% +$70.7K
2021 Q1
15 quarters
BIIB icon
19
Biogen
BIIB
$33B
$6.59M 2.44%
43,066
+7,813
+22% +$1.32M
2019 Q4
20 quarters
DEO icon
20
Diageo
DEO
$46.7B
$6.53M 2.42%
+51,395
New +$6.54M
2024 Q4
0 quarters
BMY icon
21
Bristol-Myers Squibb
BMY
$120B
$6.49M 2.41%
114,671
-45,774
-29% -$2.56M
2024 Q2
2 quarters
BUD icon
22
AB InBev
BUD
$147B
$6.03M 2.24%
120,423
-11,678
-9% -$676K
2019 Q4
20 quarters
BAX icon
23
Baxter International
BAX
$12.5B
$5.95M 2.21%
204,071
-18,632
-8% -$627K
2023 Q3
5 quarters
TROW icon
24
T. Rowe Price
TROW
$22.2B
$5.92M 2.2%
52,391
-64
-0.1% -$7.41K
2022 Q1
11 quarters
CPB icon
25
Campbell Soup
CPB
$5.76B
$5.92M 2.2%
141,340
-2,666
-2% -$120K
2024 Q1
3 quarters

Similar funds

Hillman Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Hillman Capital Management held 60 positions worth $270M, down 7.6% from $292M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Hillman Capital Management's Q4 2024 filing shows 8 new, 15 increased, 30 reduced and 6 closed positions. Its largest new stake was ASML: 12,718 shares worth $8.81M. The largest sale was Simon Property Group, an estimated $9.55M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Communication Services and Consumer Staples.

  • Hillman Capital Management's largest Q4 2024 buy was ASML: 12,718 shares worth $8.81M.
  • Hillman Capital Management added most to Nike in Q4 2024, an estimated $2.66M increase.
  • Hillman Capital Management's biggest Q4 2024 reduction was Bristol-Myers Squibb, cutting an estimated $2.56M.
  • Hillman Capital Management fully exited Simon Property Group in Q4 2024, selling an estimated $9.55M.
  • Hillman Capital Management's ten largest holdings make up 35% of its $270M portfolio in Q4 2024.
  • Hillman Capital Management opened 8 new positions and closed 6 in Q4 2024.
  • Hillman Capital Management's portfolio value fell 7.6% quarter-over-quarter to $270M.

Based on Hillman Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.